Research from Ohio State University Wexner Medical Center Provides New Study Findings on Oncolytic Virotherapy (Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus)

Press/Media

Period28 Dec 2022

Media coverage

1

Media coverage

  • TitleResearch from Ohio State University Wexner Medical Center Provides New Study Findings on Oncolytic Virotherapy (Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus)
    Media name/outletCancer Gene Therapy Daily
    Country/TerritoryUnited States
    Date28/12/22
    PersonsLarry Maxwell
View all 1
View less